# EDGAR Filing Document

**Accession Number:** 0001433660
**File Stem:** 0001433660-25-000062
**Filing Date:** 2025-11
**Character Count:** 67942
**Document Hash:** 10c244cbfeef8fe74e4ef58d564cb152
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001433660-25-000062.hdr.sgml**: 20251103

**ACCESSION NUMBER**: 0001433660-25-000062

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 13

**CONFORMED PERIOD OF REPORT**: 20251103

**ITEM INFORMATION**: Results of Operations and Financial Condition

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20251103

**DATE AS OF CHANGE**: 20251103

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** JBT Marel Corp
- **CENTRAL INDEX KEY:** 0001433660
- **STANDARD INDUSTRIAL CLASSIFICATION:** SPECIAL INDUSTRY MACHINERY (NO METALWORKING MACHINERY) [3550]
- **ORGANIZATION NAME:** 06 Technology
- **EIN:** 911650317
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-34036
- **FILM NUMBER:** 251444746

**BUSINESS ADDRESS:**
- **STREET 1:** 70 W MADISON
- **STREET 2:** SUITE 4400
- **CITY:** CHICAGO
- **STATE:** IL
- **ZIP:** 60602
- **BUSINESS PHONE:** 312 861-5900

**MAIL ADDRESS:**
- **STREET 1:** 70 W MADISON
- **STREET 2:** SUITE 4400
- **CITY:** CHICAGO
- **STATE:** IL
- **ZIP:** 60602

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** John Bean Technologies CORP
- **DATE OF NAME CHANGE:** 20080429

?xml version='1.0' encoding='ASCII'? jbt-20251103

---

| |
|:---|
| **UNITED STATES** |
| **SECURITIES AND EXCHANGE COMMISSION** |
| **Washington, D.C. 20549** |

---

**FORM 8-K** 

---

| |
|:---|
| **CURRENT REPORT** |
| **PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934** |

---

**Date of Report (Date of earliest event reported): November 3, 2025** 

**JBT Marel Corporation** 

**(Exact name of registrant as specified in its charter)**

---

| | | |
|:---|:---|:---|
| **Delaware** | **001-34036** | **91-1650317** |
| **(State or other jurisdiction of<br>incorporation or organization)** | **(Commission File Number)** | **(I.R.S. Employer<br>Identification Number)** |

---

**70 West Madison Street, Suite 4400** 

**Chicago, IL 60602** 

**(Address of principal executive offices, including Zip Code)**

**(312) 861-5900** 

**(Registrant's telephone number, including area code)**

**Not Applicable**

**(Former name or former address, if changed since last report)**

---

| | |
|:---|:---|
| Check the appropriate box below if the Forms 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: | Check the appropriate box below if the Forms 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: |
| ☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |

---

---

| | | |
|:---|:---|:---|
| Securities registered pursuant to section 12(b) of the Act: | Securities registered pursuant to section 12(b) of the Act: |  |
| **Title of each class** | **Trading symbol(s)** | **Name of each exchange on which registered** |
| Common Stock, par value $0.01 per share | JBTM | New York Stock Exchange |

---

---

| | | |
|:---|:---|:---|
| Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of Securities Exchange Act of 1934 (§240.12b-2 of this chapter). | Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of Securities Exchange Act of 1934 (§240.12b-2 of this chapter). | |
| | Emerging growth company | ☐ |
| | If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act | ☐ |

---

------

**Item 2.02 Results of Operations and Financial Condition.**

&nbsp;&nbsp;&nbsp;&nbsp;

On November 3, 2025, JBT Marel Corporation (the "Company") issued a press release announcing financial results for its third quarter ended September 30, 2025. The press release is attached hereto as Exhibit 99.1.

&nbsp;&nbsp;&nbsp;&nbsp;The information, including Exhibit 99.1, furnished in this report is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section. Registration statements or other documents filed with the Securities and Exchange Commission shall not incorporate this information by reference, except as otherwise expressly stated in such filing.

**Item 9.01 Financial Statements and Exhibits.**

&nbsp;&nbsp;&nbsp;&nbsp;(d) Exhibits.

---

| | |
|:---|:---|
| **Exhibit No.** | **Description** |
| 99.1 | <u>[Press release issued November 3, 2025](a2025q3earningsexhibit9918k.htm)</u> |
| 104 | Cover Page Interactive Data File (the cover page XBRL tags are embedded within the Inline XBRL document). |

---

------

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | |
|:---|:---|:---|
| | JBT Marel Corporation | JBT Marel Corporation |
| Date: November 3, 2025 | By: | /s/ Jessi L. Corcoran |
|  | Name | Jessi L. Corcoran |
|  | Title | Senior Vice President, Chief Accounting Officer and duly authorized officer |
|  |  | (Principal Accounting Officer) |

---

## Exhibit 99.1

**Exhibit 99.1**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;News Release

**JBT Marel Corporation**

70 W. Madison

Suite 4400

Chicago, IL 60602

**JBT Marel Corporation Reports Third Quarter 2025 Results and Raises Full Year 2025 Guidance**

***Third Quarter 2025 Highlights: (Results are from continuing operations)***

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;***◦ Achieved quarterly orders of $946 million and quarter-ending backlog of $1.3 billion***

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;***◦ Revenue totaled $1.0 billion with 49% generated from recurring revenue***

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;***◦ Income from continuing operations was $67 million, and adjusted EBITDA was $171 million***

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;***◦ Realized $14 million in year-over-year synergy savings***

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;***◦ Raising full year 2025 guidance given solid Q3 2025 performance***

**CHICAGO, November 3, 2025 - JBT Marel Corporation (NYSE and Nasdaq Iceland: JBTM)**, a leading global technology solutions provider to high-value segments of the food & beverage industry, today reported financial results for the third quarter of 2025.

"JBT Marel outperformed our third quarter earnings expectations, primarily driven by better-than-expected revenue, excellent supply chain and operational productivity, and solid cost control," said Brian Deck, Chief Executive Officer. "Given our strong third quarter results, we are raising our full year 2025 guidance, demonstrating the benefits of our diverse end markets and the enhanced scale of our combined organization."

Comparisons in this news release are to the comparable period of the prior year, unless otherwise noted. An earnings presentation with supplemental information is available on the Company's Investor Relations website at https://ir.jbtc.com/events-and-presentations/.&nbsp;&nbsp;&nbsp;&nbsp;

**JBT Marel Third Quarter 2025 Consolidated Results** 

"Our $65 million revenue outperformance was the result of higher book and ship revenue coupled with better backlog conversion from manufacturing and supply chain efficiencies, allowing us to realize revenue ahead of schedule, particularly in poultry," said Matt Meister, Chief Financial Officer. "Margins also exceeded our expectations, driven by higher volume flow through, a favorable mix of poultry equipment and shorter cycle products, and accelerated synergy savings."

------

Third quarter 2025 consolidated revenue of $1.0 billion included approximately $26 million in year-over-year foreign exchange translation benefit. Net income from continuing operations of $67 million, representing a margin of 6.7 percent, included $33 million in acquisition related amortization and depreciation expense, $7 million in restructuring related costs, and $6 million in M&A related costs.

Third quarter 2025 consolidated adjusted EBITDA was $171 million, representing a margin of 17.1 percent. Diluted earnings per share (EPS) was $1.28, and adjusted EPS was $1.94. Orders totaled $946 million, inclusive of approximately $26 million in a year-over year tailwind from foreign exchange translation, and quarter-ending backlog was $1.3 billion.

Year-to-date operating cash flow from continuing operations was $224 million, and free cash flow was $163 million. As of September 30, 2025, the Company's bank leverage ratio was 2.7x, which includes the benefit of certain run rate synergies. Net debt to trailing twelve months pro forma adjusted EBITDA was 3.1x. Additionally, the Company's liquidity as of September 30, 2025, was approximately $1.9 billion.

**JBT Marel Third Quarter 2025 Segment Results**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended September 30, 2025** | **Three Months Ended September 30, 2025** | **Three Months Ended September 30, 2025** | **Three Months Ended September 30, 2025** |
| *In millions except margin* | **JBT** | **JBT** | **Marel** | **Marel** |
| Segment revenue | $| 465 | $| 537 |
| Segment adjusted EBITDA | 71 | 71 | 100 | 100 |
| *Segment adjusted EBITDA margin* | *15.3%* | *15.3%* | *18.6%* | *18.6%* |

---

**JBT Marel Convertible Senior Notes Issuance** 

As previously announced, on September 9, 2025, JBT Marel closed its private offering of $575 million aggregate principal amount of 0.375 percent convertible senior notes due 2030. The Company utilized proceeds from the offering to execute convertible note hedge and warrant transactions and repay a portion of the borrowings outstanding under its revolving credit facility. By executing the note hedge transactions and warrant transactions, the Company effectively mitigated shareholder dilution until the share price reaches $283.42 per share.

**Synergy Actions and Target Cost Savings** 

For the third quarter of 2025, JBT Marel incurred $7 million in restructuring costs and $6 million in M&A related costs while realizing year-over-year savings of $8 million in operating expense and an additional $6 million in cost of goods sold. JBT Marel now expects to achieve in-year realized synergy savings of $40 - $45 million and is maintaining its annualized run rate savings forecast of $80 - $90 million exiting 2025.

------

**Realignment of JBT Marel Reportable Segments** 

During the fourth quarter of 2025, JBT Marel plans to realign its reportable segments to better reflect the continued integration of the Company's operating model. The realignment will include two financial reporting segments, Protein Solutions and Prepared Food and Beverage Solutions, and the Company expects to recast prior period financial results to reflect this change before its fourth quarter and full year 2025 earnings release.

The Protein Solutions segment will include JBT Marel businesses that provide solutions for initial stage processing and harvesting of animal proteins, primarily focusing on poultry, pork, fish, and beef. Examples of core technologies include primary processing systems, cut-up, bone detection and removal, portioning, and robotic harvesting.

The Prepared Food and Beverage Solutions segment will include JBT Marel businesses that offer solutions predominantly for downstream value-added preparation, preservation, and packaging of foods and beverages into ready to eat or drink products. This segment will also include capabilities for pet food, dairy, bakery, pharmaceutical and nutraceutical, and warehouse automation end markets. Examples of core technologies include forming, cutting, slicing, cooking, coating, freezing, extraction, blending, filling, preservation, packaging, and automated guided vehicles.

**JBT Marel Outlook** 

The below table reflects JBT Marel's updated consolidated guidance for full year 2025.

---

| | |
|:---|:---|
| | **Guidance** |
| *In millions except EPS and margin* | **FY 2025** |
| Revenue | $3760 - $3790 |
| Income from continuing operations margin | (1.5%) - (1.0%) |
| Adjusted EBITDA margin<sup>(1)</sup> | 15.75 - 16.0% |
| GAAP EPS | ($1.05) - ($0.75) |
| Adjusted EPS<sup>(1)</sup> | $6.10 - $6.40 |
| (1) Non-GAAP figure. Please see supplemental schedules for adjustments and reconciliations. | (1) Non-GAAP figure. Please see supplemental schedules for adjustments and reconciliations. |

---

JBT Marel expects full year 2025 revenue will include an approximate $70 - $85 million year-over-year tailwind from foreign exchange translation.

For the full year 2025, JBT Marel expects to incur certain one-time and acquisition related costs, which are included in income from continuing operations margin and GAAP EPS guidance and excluded from adjusted EPS and adjusted EBITDA margin. These include approximately $28 million in restructuring costs; $105 million in M&A related costs; $180 million in acquisition related amortization and depreciation; $147 million in non-cash, pre-tax charges related to the final settlement of the U.S. pension plan, which occurred in the first quarter; $12 million in interest expense from M&A bridge financing fees and related costs, which was incurred in the first quarter; and $11 million in loss on investment from an impairment charge related to a joint-venture, which occurred in the second quarter.

------

For the full year 2025, net interest expense is anticipated to be $105 million, which includes $12 million in M&A bridge financing fees and related costs. Other income related to cross currency swaps on the Term Loan B is expected to be approximately $10 million. Total depreciation and amortization is estimated to be approximately $265 million, including approximately $180 million in acquisition related amortization and depreciation.

For the fourth quarter of 2025, the tax rate assumed for GAAP EPS is expected to be approximately 21 percent, and the tax rate assumed for adjusted EPS is expected to be approximately 25 percent.

**Earnings Conference Call**

A conference call is scheduled for 10:00 a.m. ET / 15:00 GMT on Tuesday, November 4, 2025, to discuss third quarter 2025 results. A simultaneous webcast and audio replay of the call will be available on the Company's Investor Relations website at https://ir.jbtc.com/events-and-presentations/.

*##*

***About JBT Marel Corporation***

*JBT Marel Corporation (NYSE and Nasdaq Iceland: JBTM) is a leading global technology solutions provider to high-value segments of the food & beverage industry. JBT Marel brings together the complementary strengths of both the JBT and Marel legacy organizations to transform the future of food. JBT Marel provides unique and integrated solutions offerings by designing, manufacturing, and servicing cutting-edge technology, systems, and software for a broad range of food and beverage end markets. JBT Marel aims to create better outcomes for customers by optimizing food yield and efficiency, improving food safety and quality, and enhancing uptime and proactive maintenance, all while reducing waste and resource use across the global food supply chain. JBT Marel operates sales, service, manufacturing and sourcing operations in more than 30 countries. For more information, please visit www.jbtmarel.com.* 

***Non-GAAP Measures and Reconciliations to GAAP Measures***

*Adjusted EBITDA, Adjusted EBITDA margin, Adjusted income from continuing operations, Adjusted diluted earnings per share from continuing operations ("Adjusted EPS"), and free cash flow are non-GAAP financial measures. JBT Marel provides non-GAAP financial measures in order to increase transparency in our operating results and trends. These non-GAAP measures eliminate certain costs or benefits from, or change the calculation of, a measure as calculated under U.S. GAAP. By eliminating these items, JBT Marel provides a more meaningful comparison of our ongoing operating results, consistent with how management evaluates performance. Management uses these non-GAAP measures in financial and operational evaluation, planning and forecasting. These calculations may differ from similarly-titled measures used by other companies. The non-GAAP financial measures disclosed are not intended to be used as a substitute for, nor should they be considered in isolation of, financial measures prepared in accordance with U.S. GAAP. Reconciliations of non-GAAP financial measures can be found in the supplemental schedules to this release.* 

------

***Forward-Looking Statements***

*This release contains forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995. Forward-looking statements are information of a non-historical nature and are subject to risks and uncertainties that are beyond JBT Marel's ability to control. The inclusion of this forward-looking information should not be regarded as a representation by us or any other person that the future plans, estimates or expectations contemplated by JBT Marel will be achieved. These forward-looking statements include, among others, statements relating to our business and our results of operations, including our outlook, the benefits or results of our acquisition of Marel hf. (the "Marel Transaction"), our strategic plans, our restructuring plans and expected cost savings from those plans and our liquidity. The factors that could cause our actual results to differ materially from expectations include, but are not limited to, the following factors: the inability to successfully integrate the legacy businesses of JBT and Marel, operationally, technologically, culturally or otherwise, in a manner that permits the combined company to achieve the benefits and synergies anticipated from the Marel Transaction on the anticipated timeline or at all; fluctuations in our financial results; changes to tariffs, trade regulation, quotas, or duties; deterioration of economic conditions, including impacts from supply chain delays and reduced material or component availability; unanticipated delays or accelerations in our sales cycles; inflationary pressures, including increases in energy, raw material, freight and labor costs; disruptions in the political, regulatory, economic and social conditions of the countries in which we conduct business; the potential effects of the U.S. government shutdown that began in October 2025; fluctuations in currency exchange rates and interest rates; changes in food consumption patterns; impacts of pandemic illnesses, food borne illnesses and diseases to various agricultural products; weather conditions and natural disasters; the impact of climate change and environmental protection initiatives; acts of terrorism or war, including the ongoing conflicts in Ukraine and the Middle East; termination or loss of major customer contracts and risks associated with fixed-price contracts, particularly during periods of high inflation; customer sourcing initiatives; competition and innovation in our industries; our ability to develop and introduce new or enhanced products and services and keep pace with technological developments; difficulty in developing, preserving and protecting our intellectual property or defending claims of infringement; catastrophic loss at any of our facilities and business continuity of our information systems; cyber-security risks such as network intrusion or ransomware schemes; loss of key management and other personnel; potential liability arising out of the installation or use of our systems; our ability to comply with U.S. and international laws governing our operations and industries; increases in tax liabilities; work stoppages; our ability to remediate the material weaknesses relating to the Marel financial statements; availability of and access to financial and other resources; and the factors described under the captions "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" in our most recent Annual Report on Form 10-K, our Quarterly Report on Form 10-Q for the six months ended June 30, 2025, and any future Quarterly Report on Form 10-Q. If one or more of those or other risks or uncertainties materialize, or if our underlying assumptions prove to be incorrect, actual results may vary materially from what we projected. Consequently, actual events and results may vary significantly from those included in or contemplated by our forward-looking statements. The forward-looking statements included in this release are made only as of the date hereof, and we undertake no obligation to publicly update or revise any forward-looking statement made by us or on our behalf, whether as a result of new information, future developments, subsequent events or changes in circumstances or otherwise.*

Investors & Media:

Marlee Spangler

JBTMarel.IR@jbtc.com

+1 (312) 861-5784

------

---

| | | | | |
|:---|:---|:---|:---|:---|
| **JBT MAREL CORPORATION** | **JBT MAREL CORPORATION** | **JBT MAREL CORPORATION** | **JBT MAREL CORPORATION** | **JBT MAREL CORPORATION** |
| **CONDENSED CONSOLIDATED STATEMENTS OF INCOME** | **CONDENSED CONSOLIDATED STATEMENTS OF INCOME** | **CONDENSED CONSOLIDATED STATEMENTS OF INCOME** | **CONDENSED CONSOLIDATED STATEMENTS OF INCOME** | **CONDENSED CONSOLIDATED STATEMENTS OF INCOME** |
| **(Unaudited and in millions, except per share data)** | **(Unaudited and in millions, except per share data)** | **(Unaudited and in millions, except per share data)** | **(Unaudited and in millions, except per share data)** | **(Unaudited and in millions, except per share data)** |
| | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
|  | **2025** | **2024** | **2025** | **2024** |
| &nbsp;&nbsp;&nbsp;&nbsp;Revenue | $1001.3 | $453.8 | $2790.2 | $1248.4 |
| &nbsp;&nbsp;&nbsp;&nbsp;Cost of sales | 641.5 | 290.2 | 1803.7 | 801.3 |
| Gross profit | 359.8 | 163.6 | 986.5 | 447.1 |
| *Gross profit margin* | *35.9%* | *36.1%* | *35.4%* | *35.8%* |
| &nbsp;&nbsp;&nbsp;&nbsp;Selling, general and administrative expense | 222.0 | 111.6 | 754.1 | 325.7 |
| &nbsp;&nbsp;&nbsp;&nbsp;Research and development | 28.7 | 5.4 | 93.2 | 17.6 |
| &nbsp;&nbsp;&nbsp;&nbsp;Restructuring expense | 7.0 | (0.2) | 22.1 | 1.1 |
| Operating income | 102.1 | 46.8 | 117.1 | 102.7 |
| *Operating income margin* | *10.2%* | *10.3%* | *4.2%* | *8.2%* |
| &nbsp;&nbsp;&nbsp;&nbsp;Pension expense, other than service cost | 0.2 | 1.0 | 147.2 | 3.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;Loss on investment |  |  | 10.6 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Other (income) | (3.1) |  | (8.1) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net interest expense (income) | 21.3 | (1.8) | 91.3 | (6.2) |
| Income (loss) from continuing operations before income taxes | 83.7 | 47.6 | (123.9) | 105.9 |
| &nbsp;&nbsp;&nbsp;&nbsp;Income tax provision (benefit) | 17.1 | 9.5 | (21.2) | 14.3 |
| &nbsp;&nbsp;&nbsp;&nbsp;Equity in net earnings of unconsolidated affiliate | 0.2 |  | (0.1) | (0.1) |
| Income (loss) from continuing operations | 66.8 | 38.1 | (102.8) | 91.5 |
| &nbsp;&nbsp;&nbsp;&nbsp;Income from discontinued operations, net of taxes | (0.8) | 0.8 | (0.8) | 0.9 |
| Net income (loss) | $66.0 | $38.9 | $(103.6) | $92.4 |
| Basic earnings (loss) per share from: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Continuing operations | $1.28 | $1.19 | $(1.98) | $2.86 |
| &nbsp;&nbsp;&nbsp;&nbsp;Discontinued operations | (0.02) | 0.03 | (0.02) | 0.03 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net income (loss) | $1.26 | $1.22 | $(2.00) | $2.89 |
| Diluted earnings (loss) per share from: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Continuing operations | $1.28 | $1.18 | $(1.98) | $2.84 |
| &nbsp;&nbsp;&nbsp;&nbsp;Discontinued operations | (0.02) | 0.03 | (0.02) | 0.03 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net income (loss) | $1.26 | $1.21 | $(2.00) | $2.87 |
| Weighted average shares outstanding |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Basic | 52.0 | 32.0 | 51.9 | 32.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;Diluted | 52.3 | 32.2 | 51.9 | 32.2 |
| Other business information from continuing operations: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Inbound orders | $946.3 | $439.6 | $2800.1 | $1265.2 |
| &nbsp;&nbsp;&nbsp;&nbsp;Orders backlog |  |  | $1338.9 | $698.1 |

---

------

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **JBT MAREL CORPORATION** | **JBT MAREL CORPORATION** | **JBT MAREL CORPORATION** | **JBT MAREL CORPORATION** | **JBT MAREL CORPORATION** | **JBT MAREL CORPORATION** |
| **NON-GAAP FINANCIAL MEASURES** | **NON-GAAP FINANCIAL MEASURES** | **NON-GAAP FINANCIAL MEASURES** | **NON-GAAP FINANCIAL MEASURES** | **NON-GAAP FINANCIAL MEASURES** | **NON-GAAP FINANCIAL MEASURES** |
| **RECONCILIATION OF DILUTED EARNINGS PER SHARE TO ADJUSTED DILUTED EARNINGS PER SHARE** | **RECONCILIATION OF DILUTED EARNINGS PER SHARE TO ADJUSTED DILUTED EARNINGS PER SHARE** | **RECONCILIATION OF DILUTED EARNINGS PER SHARE TO ADJUSTED DILUTED EARNINGS PER SHARE** | **RECONCILIATION OF DILUTED EARNINGS PER SHARE TO ADJUSTED DILUTED EARNINGS PER SHARE** | **RECONCILIATION OF DILUTED EARNINGS PER SHARE TO ADJUSTED DILUTED EARNINGS PER SHARE** | **RECONCILIATION OF DILUTED EARNINGS PER SHARE TO ADJUSTED DILUTED EARNINGS PER SHARE** |
| **(Unaudited and in millions, except per share data)** | **(Unaudited and in millions, except per share data)** | **(Unaudited and in millions, except per share data)** | **(Unaudited and in millions, except per share data)** | **(Unaudited and in millions, except per share data)** | **(Unaudited and in millions, except per share data)** |
| | **Q3 2025** | **Q2 2025** | **Q1 2025** | **Q4 2024** | **Q3 2024** |
| Income (loss) from continuing operations | $66.8 | $3.4 | $(173.0) | $(6.9) | $38.1 |
| Non-GAAP adjustments |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Restructuring related costs<sup>(1)</sup> | 7.4 | 5.6 | 10.6 | 0.3 | (0.2) |
| &nbsp;&nbsp;&nbsp;&nbsp;M&A related costs<sup>(2)</sup> | 5.8 | 20.0 | 74.4 | 53.3 | 12.9 |
| &nbsp;&nbsp;&nbsp;&nbsp;Loss on investment |  | 10.6 |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Amortization of bridge financing debt issuance cost |  |  | 12.4 | 4.7 | 1.2 |
| &nbsp;&nbsp;&nbsp;&nbsp;Acquisition related amortization and depreciation | 33.1 | 58.3 | 41.7 | 11.4 | 11.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;Impact on tax provision from Non-GAAP adjustments<sup>(3)</sup> | (11.4) | (20.2) | (31.0) | (16.7) | (6.3) |
| &nbsp;&nbsp;&nbsp;&nbsp;Recognition of non-cash pension plan related settlement costs |  |  | 146.9 | 23.3 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Impact on tax provision from non-cash pension plan related settlement costs |  |  | (37.1) | (6.0) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Discrete tax adjustment from M&A activity |  |  | 5.4 |  |  |
| Adjusted income from continuing operations | $101.7 | $77.7 | $50.3 | $63.4 | $56.7 |
| Income (loss) from continuing operations | $66.8 | $3.4 | $(173.0) | $(6.9) | $38.1 |
| Total shares and dilutive securities | 52.3 | 52.2 | 51.7 | 32.2 | 32.2 |
| Diluted earnings per share from continuing operations | $1.28 | $0.07 | $(3.35) | $(0.21) | $1.18 |
| Adjusted income from continuing operations | $101.7 | $77.7 | $50.3 | $63.4 | $56.7 |
| Total shares and dilutive securities | 52.3 | 52.2 | 51.9 | 32.2 | 32.2 |
| Adjusted diluted earnings per share from continuing operations | $1.94 | $1.49 | $0.97 | $1.97 | $1.76 |
| (1) Costs incurred as a direct result of the restructuring program are excluded because they are not part of the ongoing operations of our underlying business. | (1) Costs incurred as a direct result of the restructuring program are excluded because they are not part of the ongoing operations of our underlying business. | (1) Costs incurred as a direct result of the restructuring program are excluded because they are not part of the ongoing operations of our underlying business. | (1) Costs incurred as a direct result of the restructuring program are excluded because they are not part of the ongoing operations of our underlying business. | (1) Costs incurred as a direct result of the restructuring program are excluded because they are not part of the ongoing operations of our underlying business. | (1) Costs incurred as a direct result of the restructuring program are excluded because they are not part of the ongoing operations of our underlying business. |
| (2) M&A related costs for the three months ended September 30, 2025, include advisory and transaction related costs for both potential and completed M&A transactions and strategy of $0.5 million, amortization of inventory step-up from business combinations of $(0.2) million, and integration costs of $5.5 million. M&A related costs are excluded as they are generally short-term in nature and turn over quickly or are not part of the ongoing operations of our underlying business. | (2) M&A related costs for the three months ended September 30, 2025, include advisory and transaction related costs for both potential and completed M&A transactions and strategy of $0.5 million, amortization of inventory step-up from business combinations of $(0.2) million, and integration costs of $5.5 million. M&A related costs are excluded as they are generally short-term in nature and turn over quickly or are not part of the ongoing operations of our underlying business. | (2) M&A related costs for the three months ended September 30, 2025, include advisory and transaction related costs for both potential and completed M&A transactions and strategy of $0.5 million, amortization of inventory step-up from business combinations of $(0.2) million, and integration costs of $5.5 million. M&A related costs are excluded as they are generally short-term in nature and turn over quickly or are not part of the ongoing operations of our underlying business. | (2) M&A related costs for the three months ended September 30, 2025, include advisory and transaction related costs for both potential and completed M&A transactions and strategy of $0.5 million, amortization of inventory step-up from business combinations of $(0.2) million, and integration costs of $5.5 million. M&A related costs are excluded as they are generally short-term in nature and turn over quickly or are not part of the ongoing operations of our underlying business. | (2) M&A related costs for the three months ended September 30, 2025, include advisory and transaction related costs for both potential and completed M&A transactions and strategy of $0.5 million, amortization of inventory step-up from business combinations of $(0.2) million, and integration costs of $5.5 million. M&A related costs are excluded as they are generally short-term in nature and turn over quickly or are not part of the ongoing operations of our underlying business. | (2) M&A related costs for the three months ended September 30, 2025, include advisory and transaction related costs for both potential and completed M&A transactions and strategy of $0.5 million, amortization of inventory step-up from business combinations of $(0.2) million, and integration costs of $5.5 million. M&A related costs are excluded as they are generally short-term in nature and turn over quickly or are not part of the ongoing operations of our underlying business. |
| (3) Impact on tax provision was calculated using the enacted rate for the relevant jurisdiction for each period shown. | (3) Impact on tax provision was calculated using the enacted rate for the relevant jurisdiction for each period shown. | (3) Impact on tax provision was calculated using the enacted rate for the relevant jurisdiction for each period shown. | (3) Impact on tax provision was calculated using the enacted rate for the relevant jurisdiction for each period shown. | (3) Impact on tax provision was calculated using the enacted rate for the relevant jurisdiction for each period shown. | (3) Impact on tax provision was calculated using the enacted rate for the relevant jurisdiction for each period shown. |
| The above table reports adjusted income from continuing operations and adjusted diluted earnings per share from continuing operations, which are non-GAAP financial measures. We use these measures internally to make operating decisions and for the planning and forecasting of future periods, and therefore provide this information to investors because we believe it allows more meaningful period-to-period comparisons of our ongoing operating results, without the fluctuations in the amount of certain costs that do not reflect our underlying operating results. | The above table reports adjusted income from continuing operations and adjusted diluted earnings per share from continuing operations, which are non-GAAP financial measures. We use these measures internally to make operating decisions and for the planning and forecasting of future periods, and therefore provide this information to investors because we believe it allows more meaningful period-to-period comparisons of our ongoing operating results, without the fluctuations in the amount of certain costs that do not reflect our underlying operating results. | The above table reports adjusted income from continuing operations and adjusted diluted earnings per share from continuing operations, which are non-GAAP financial measures. We use these measures internally to make operating decisions and for the planning and forecasting of future periods, and therefore provide this information to investors because we believe it allows more meaningful period-to-period comparisons of our ongoing operating results, without the fluctuations in the amount of certain costs that do not reflect our underlying operating results. | The above table reports adjusted income from continuing operations and adjusted diluted earnings per share from continuing operations, which are non-GAAP financial measures. We use these measures internally to make operating decisions and for the planning and forecasting of future periods, and therefore provide this information to investors because we believe it allows more meaningful period-to-period comparisons of our ongoing operating results, without the fluctuations in the amount of certain costs that do not reflect our underlying operating results. | The above table reports adjusted income from continuing operations and adjusted diluted earnings per share from continuing operations, which are non-GAAP financial measures. We use these measures internally to make operating decisions and for the planning and forecasting of future periods, and therefore provide this information to investors because we believe it allows more meaningful period-to-period comparisons of our ongoing operating results, without the fluctuations in the amount of certain costs that do not reflect our underlying operating results. | The above table reports adjusted income from continuing operations and adjusted diluted earnings per share from continuing operations, which are non-GAAP financial measures. We use these measures internally to make operating decisions and for the planning and forecasting of future periods, and therefore provide this information to investors because we believe it allows more meaningful period-to-period comparisons of our ongoing operating results, without the fluctuations in the amount of certain costs that do not reflect our underlying operating results. |

---

------

---

| | | | | |
|:---|:---|:---|:---|:---|
| **JBT MAREL CORPORATION** | **JBT MAREL CORPORATION** | **JBT MAREL CORPORATION** | **JBT MAREL CORPORATION** | **JBT MAREL CORPORATION** |
| **NON-GAAP FINANCIAL MEASURES** | **NON-GAAP FINANCIAL MEASURES** | **NON-GAAP FINANCIAL MEASURES** | **NON-GAAP FINANCIAL MEASURES** | **NON-GAAP FINANCIAL MEASURES** |
| **RECONCILIATION OF INCOME FROM CONTINUING OPERATIONS TO ADJUSTED EBITDA** | **RECONCILIATION OF INCOME FROM CONTINUING OPERATIONS TO ADJUSTED EBITDA** | **RECONCILIATION OF INCOME FROM CONTINUING OPERATIONS TO ADJUSTED EBITDA** | **RECONCILIATION OF INCOME FROM CONTINUING OPERATIONS TO ADJUSTED EBITDA** | **RECONCILIATION OF INCOME FROM CONTINUING OPERATIONS TO ADJUSTED EBITDA** |
| **(Unaudited and in millions)** | **(Unaudited and in millions)** | **(Unaudited and in millions)** | **(Unaudited and in millions)** | **(Unaudited and in millions)** |
| | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
|  | **2025** | **2024** | **2025** | **2024** |
| Income (loss) from continuing operations | 66.8 | 38.1 | (102.8) | 91.5 |
| &nbsp;&nbsp;&nbsp;&nbsp;Income tax provision (benefit) | 17.1 | 9.5 | (21.2) | 14.3 |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest expense (income), net | 21.3 | (1.8) | 91.3 | (6.2) |
| &nbsp;&nbsp;&nbsp;&nbsp;Other financing (income) <sup>(1)</sup> | (3.1) |  | (8.1) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Loss on investment |  |  | 10.6 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Pension expense, other than service cost <sup>(2)</sup> | 0.2 | 1.0 | 147.2 | 3.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;Restructuring related costs <sup>(3)</sup> | 7.4 | (0.2) | 23.6 | 1.1 |
| &nbsp;&nbsp;&nbsp;&nbsp;M&A related costs <sup>(4)</sup> | 5.8 | 12.9 | 100.2 | 32.6 |
| &nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization <sup>(5)</sup> | 55.4 | 22.2 | 198.5 | 66.5 |
| Adjusted EBITDA from continuing operations | 170.9 | 81.7 | 439.3 | 202.8 |
| Total revenue | 1001.3 | 453.8 | 2790.2 | 1248.4 |
| *Income (loss) from continuing operations margin* | *6.7%* | *8.4%* | *(3.7)%* | *7.3%* |
| *Adjusted EBITDA margin* | *17.1%* | *18.0%* | *15.7%* | *16.2%* |
| (1) Other financing income represents transaction gains from fair value hedges on our foreign currency denominated debt, and are considered non-operating as they relate to our cost of borrowing on this debt. | (1) Other financing income represents transaction gains from fair value hedges on our foreign currency denominated debt, and are considered non-operating as they relate to our cost of borrowing on this debt. | (1) Other financing income represents transaction gains from fair value hedges on our foreign currency denominated debt, and are considered non-operating as they relate to our cost of borrowing on this debt. | (1) Other financing income represents transaction gains from fair value hedges on our foreign currency denominated debt, and are considered non-operating as they relate to our cost of borrowing on this debt. | (1) Other financing income represents transaction gains from fair value hedges on our foreign currency denominated debt, and are considered non-operating as they relate to our cost of borrowing on this debt. |
| (2) Pension expense, other than service cost is excluded as it represents all non service-related pension expense, which consists of non-cash interest cost, expected return on plan assets, amortization of actuarial gains and losses, and settlement charges. | (2) Pension expense, other than service cost is excluded as it represents all non service-related pension expense, which consists of non-cash interest cost, expected return on plan assets, amortization of actuarial gains and losses, and settlement charges. | (2) Pension expense, other than service cost is excluded as it represents all non service-related pension expense, which consists of non-cash interest cost, expected return on plan assets, amortization of actuarial gains and losses, and settlement charges. | (2) Pension expense, other than service cost is excluded as it represents all non service-related pension expense, which consists of non-cash interest cost, expected return on plan assets, amortization of actuarial gains and losses, and settlement charges. | (2) Pension expense, other than service cost is excluded as it represents all non service-related pension expense, which consists of non-cash interest cost, expected return on plan assets, amortization of actuarial gains and losses, and settlement charges. |
| (3) Costs incurred as a direct result of the restructuring program are excluded because they are not part of the ongoing operations of our underlying business. | (3) Costs incurred as a direct result of the restructuring program are excluded because they are not part of the ongoing operations of our underlying business. | (3) Costs incurred as a direct result of the restructuring program are excluded because they are not part of the ongoing operations of our underlying business. | (3) Costs incurred as a direct result of the restructuring program are excluded because they are not part of the ongoing operations of our underlying business. | (3) Costs incurred as a direct result of the restructuring program are excluded because they are not part of the ongoing operations of our underlying business. |
| (4) M&A related costs for the three and nine months ended September 30, 2025, respectively, include advisory and transaction related costs for both potential and completed M&A transactions and strategy of $0.5 million and $58.2 million, amortization of inventory step-up from business combinations of $(0.2) million and $19.7 million, and integration costs of $5.5 million and $22.3 million. M&A related costs are excluded as they are generally short-term in nature and turn over quickly or are not part of the ongoing operations of our underlying business. | (4) M&A related costs for the three and nine months ended September 30, 2025, respectively, include advisory and transaction related costs for both potential and completed M&A transactions and strategy of $0.5 million and $58.2 million, amortization of inventory step-up from business combinations of $(0.2) million and $19.7 million, and integration costs of $5.5 million and $22.3 million. M&A related costs are excluded as they are generally short-term in nature and turn over quickly or are not part of the ongoing operations of our underlying business. | (4) M&A related costs for the three and nine months ended September 30, 2025, respectively, include advisory and transaction related costs for both potential and completed M&A transactions and strategy of $0.5 million and $58.2 million, amortization of inventory step-up from business combinations of $(0.2) million and $19.7 million, and integration costs of $5.5 million and $22.3 million. M&A related costs are excluded as they are generally short-term in nature and turn over quickly or are not part of the ongoing operations of our underlying business. | (4) M&A related costs for the three and nine months ended September 30, 2025, respectively, include advisory and transaction related costs for both potential and completed M&A transactions and strategy of $0.5 million and $58.2 million, amortization of inventory step-up from business combinations of $(0.2) million and $19.7 million, and integration costs of $5.5 million and $22.3 million. M&A related costs are excluded as they are generally short-term in nature and turn over quickly or are not part of the ongoing operations of our underlying business. | (4) M&A related costs for the three and nine months ended September 30, 2025, respectively, include advisory and transaction related costs for both potential and completed M&A transactions and strategy of $0.5 million and $58.2 million, amortization of inventory step-up from business combinations of $(0.2) million and $19.7 million, and integration costs of $5.5 million and $22.3 million. M&A related costs are excluded as they are generally short-term in nature and turn over quickly or are not part of the ongoing operations of our underlying business. |
| (5) Depreciation and amortization, including the acquisition related amortization and depreciation expense, is excluded to determine EBITDA. | (5) Depreciation and amortization, including the acquisition related amortization and depreciation expense, is excluded to determine EBITDA. | (5) Depreciation and amortization, including the acquisition related amortization and depreciation expense, is excluded to determine EBITDA. | (5) Depreciation and amortization, including the acquisition related amortization and depreciation expense, is excluded to determine EBITDA. | (5) Depreciation and amortization, including the acquisition related amortization and depreciation expense, is excluded to determine EBITDA. |
| The above table reports Adjusted EBITDA and Adjusted EBITDA margin, which are non-GAAP financial measures. We use Adjusted EBITDA and Adjusted EBITDA margin internally to make operating decisions and believe that Adjusted EBITDA is useful to investors as a measure of the Company's operational performance and a way to evaluate and compare operating performance against peers in the Company's industry. | The above table reports Adjusted EBITDA and Adjusted EBITDA margin, which are non-GAAP financial measures. We use Adjusted EBITDA and Adjusted EBITDA margin internally to make operating decisions and believe that Adjusted EBITDA is useful to investors as a measure of the Company's operational performance and a way to evaluate and compare operating performance against peers in the Company's industry. | The above table reports Adjusted EBITDA and Adjusted EBITDA margin, which are non-GAAP financial measures. We use Adjusted EBITDA and Adjusted EBITDA margin internally to make operating decisions and believe that Adjusted EBITDA is useful to investors as a measure of the Company's operational performance and a way to evaluate and compare operating performance against peers in the Company's industry. | The above table reports Adjusted EBITDA and Adjusted EBITDA margin, which are non-GAAP financial measures. We use Adjusted EBITDA and Adjusted EBITDA margin internally to make operating decisions and believe that Adjusted EBITDA is useful to investors as a measure of the Company's operational performance and a way to evaluate and compare operating performance against peers in the Company's industry. | The above table reports Adjusted EBITDA and Adjusted EBITDA margin, which are non-GAAP financial measures. We use Adjusted EBITDA and Adjusted EBITDA margin internally to make operating decisions and believe that Adjusted EBITDA is useful to investors as a measure of the Company's operational performance and a way to evaluate and compare operating performance against peers in the Company's industry. |

---

---

| | | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **JBT MAREL CORPORATION** | **JBT MAREL CORPORATION** | **JBT MAREL CORPORATION** | **JBT MAREL CORPORATION** | **JBT MAREL CORPORATION** | **JBT MAREL CORPORATION** | **JBT MAREL CORPORATION** | **JBT MAREL CORPORATION** | **JBT MAREL CORPORATION** | **JBT MAREL CORPORATION** | **JBT MAREL CORPORATION** | **JBT MAREL CORPORATION** | **JBT MAREL CORPORATION** |
| **SEGMENT RESULTS** | **SEGMENT RESULTS** | **SEGMENT RESULTS** | **SEGMENT RESULTS** | **SEGMENT RESULTS** | **SEGMENT RESULTS** | **SEGMENT RESULTS** | **SEGMENT RESULTS** | **SEGMENT RESULTS** | **SEGMENT RESULTS** | **SEGMENT RESULTS** | **SEGMENT RESULTS** | **SEGMENT RESULTS** |
| **(Unaudited and in millions)** | **(Unaudited and in millions)** | **(Unaudited and in millions)** | **(Unaudited and in millions)** | **(Unaudited and in millions)** | **(Unaudited and in millions)** | **(Unaudited and in millions)** | **(Unaudited and in millions)** | **(Unaudited and in millions)** | **(Unaudited and in millions)** | **(Unaudited and in millions)** | **(Unaudited and in millions)** | **(Unaudited and in millions)** |
| | **Three Months Ended September 30, 2025** | **Three Months Ended September 30, 2025** | **Three Months Ended September 30, 2025** | **Three Months Ended September 30, 2025** | **Three Months Ended September 30, 2025** | **Three Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** | **Nine Months Ended September 30, 2025** |
| | **JBT** | **JBT** | **Marel** | **Marel** | **Total** | **Total** | **JBT** | **JBT** | **Marel** | **Marel** | **Total** | **Total** |
| Segment revenue | $| 464.8 | $| 536.5 | $| 1001.3 | $| 1328.2 | $| 1462.0 | $| 2790.2 |
| Segment adjusted EBITDA | $| 71.3 | $| 99.6 | $| 170.9 | $| 213.5 | $| 225.8 | $| 439.3 |
| *Segment adjusted EBITDA margin* | *15.3%* | *15.3%* | *18.6%* | *18.6%* | *17.1%* | *17.1%* | *16.1%* | *16.1%* | *15.4%* | *15.4%* | *15.7%* | *15.7%* |

---

------

---

| | | |
|:---|:---|:---|
| **JBT MAREL CORPORATION** | **JBT MAREL CORPORATION** | **JBT MAREL CORPORATION** |
| **CONDENSED CONSOLIDATED BALANCE SHEETS** | **CONDENSED CONSOLIDATED BALANCE SHEETS** | **CONDENSED CONSOLIDATED BALANCE SHEETS** |
| **(Unaudited and in millions)** | **(Unaudited and in millions)** | **(Unaudited and in millions)** |
| | **September 30, 2025** | **December 31, 2024** |
| **Assets** | | |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash and cash equivalents | $114.9 | $1228.4 |
| &nbsp;&nbsp;&nbsp;&nbsp;Restricted cash | 18.4 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Trade receivables, net of allowances | 542.1 | 335.1 |
| &nbsp;&nbsp;&nbsp;&nbsp;Inventories | 669.4 | 233.1 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other current assets | 195.1 | 66.7 |
| Total current assets | 1539.9 | 1863.3 |
| &nbsp;&nbsp;&nbsp;&nbsp;Property, plant and equipment, net | 798.9 | 233.7 |
| &nbsp;&nbsp;&nbsp;&nbsp;Goodwill | 3419.2 | 769.1 |
| &nbsp;&nbsp;&nbsp;&nbsp;Intangible assets, net | 2163.3 | 340.9 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other assets | 278.1 | 206.8 |
| Total Assets | $8199.4 | $3413.8 |
| **Liabilities and Stockholders' Equity** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Short-term debt and current portion of long-term debt | $411.4 | $— |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounts payable, trade and other | 300.5 | 131.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;Advance and progress payments | 499.4 | 194.1 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other current liabilities | 437.8 | 210.4 |
| Total current liabilities | 1649.1 | 535.5 |
| &nbsp;&nbsp;&nbsp;&nbsp;Long-term debt, less current portion | 1495.3 | 1252.1 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accrued pension and other post-retirement benefits, less current portion | 17.4 | 19.3 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other liabilities | 616.8 | 62.7 |
| &nbsp;&nbsp;&nbsp;&nbsp;Common stock and additional paid-in capital | 2720.0 | 232.8 |
| &nbsp;&nbsp;&nbsp;&nbsp;Retained earnings | 1416.9 | 1535.9 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accumulated other comprehensive loss | 283.9 | (224.5) |
| Total stockholders' equity | 4420.8 | 1544.2 |
| Total liabilities and stockholders' equity | $8199.4 | $3413.8 |

---

------

---

| | | |
|:---|:---|:---|
| **JBT MAREL CORPORATION** | **JBT MAREL CORPORATION** | **JBT MAREL CORPORATION** |
| **CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS** | **CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS** | **CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS** |
| **(Unaudited and in millions)** | **(Unaudited and in millions)** | **(Unaudited and in millions)** |
| | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
|  | **2025** | **2024** |
| **Cash flows from continuing operating activities** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net (loss) income | $(103.6) | $92.4 |
| &nbsp;&nbsp;&nbsp;&nbsp;Less: (Loss) income from discontinued operations, net of taxes | (0.8) | 0.9 |
| &nbsp;&nbsp;&nbsp;&nbsp;(Loss) income from continuing operations | (102.8) | 91.5 |
| **Adjustments to reconcile income to cash provided by operating activities** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | 198.5 | 66.5 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Stock-based compensation | 17.1 | 11.4 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other | 200.3 | 9.3 |
| **Changes in operating assets and liabilities** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Trade accounts receivable, net | 31.5 | (47.4) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Inventories | (68.6) | (16.6) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts payable, trade and other | 23.0 | 9.7 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Advance and progress payments | 2.6 | (10.5) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other - assets and liabilities, net | (77.3) | (10.0) |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash provided by continuing operating activities | 224.3 | 103.9 |
| **Cash flows from continuing investing activities** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Acquisitions, net of cash acquired | (1746.0) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Payments related to discontinued operations | (0.1) | (4.8) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Capital expenditures | (69.7) | (27.9) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other | 4.5 | 0.9 |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash required by continuing investing activities | (1811.3) | (31.8) |
| **Cash flows from continuing financing activities** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net payments for domestic credit facilities | (829.0) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net proceeds from Term Loan B, net of debt issuance costs | 892.4 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Proceeds from issuance of 2030 convertible senior notes, net of debt issuance costs | 559.4 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Purchase of convertible bond hedge | (78.8) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Proceeds from sale of warrants | 51.1 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Settlement of deal contingent hedge | (42.5) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dividends | (15.7) | (9.6) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other | (46.0) | (13.5) |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash provided (required) by continuing financing activities | 490.9 | (23.1) |
| Net (decrease) increase in cash from continuing operations | (1096.1) | 49.0 |
| Net cash provided by discontinued operations |  | 0.8 |
| Effect of foreign exchange rate changes on cash and cash equivalents | 1.0 | 1.4 |
| Net (decrease) increase in cash, cash equivalents and restricted cash | (1095.1) | 51.2 |
| Cash and cash equivalents from continuing operations, beginning of period | 1228.4 | 483.3 |
| &nbsp;&nbsp;&nbsp;&nbsp;Add: Cash and cash equivalents from discontinued operations, beginning of period |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Add: Net (decrease) increase in cash and cash equivalents | (1095.1) | 51.2 |
| &nbsp;&nbsp;&nbsp;&nbsp;Less: Cash and cash equivalents from discontinued operations, end of period |  |  |
| Cash, cash equivalents and restricted cash from continuing operations, end of period | $133.3 | $534.5 |

---

------

---

| | | |
|:---|:---|:---|
| **JBT MAREL CORPORATION** | **JBT MAREL CORPORATION** | **JBT MAREL CORPORATION** |
| **NON-GAAP FINANCIAL MEASURES** | **NON-GAAP FINANCIAL MEASURES** | **NON-GAAP FINANCIAL MEASURES** |
| **FREE CASH FLOW** | **FREE CASH FLOW** | **FREE CASH FLOW** |
| **(Unaudited and in millions)** | **(Unaudited and in millions)** | **(Unaudited and in millions)** |
| | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
|  | **2025** | **2024** |
| Cash provided by continuing operating activities | $224.3 | $103.9 |
| &nbsp;&nbsp;&nbsp;&nbsp;Less: capital expenditures | 69.7 | 27.9 |
| &nbsp;&nbsp;&nbsp;&nbsp;Plus: proceeds from disposal of assets | 4.5 | 0.9 |
| &nbsp;&nbsp;&nbsp;&nbsp;Plus: pension contributions | 3.9 | 2.3 |
| Free cash flow (FCF) | $163.0 | $79.2 |
| The above table reports free cash flow, which is a non-GAAP financial measure. We use free cash flow internally as a key indicator of our liquidity and ability to service debt, invest in business combinations, and return money to shareholders and believe this information is useful to investors because it provides an understanding of the cash available to fund these initiatives. For free cash flow purposes, we consider contributions to pension plans to be more comparable to payment of debt, and therefore exclude these contributions from the calculation of free cash flow. | The above table reports free cash flow, which is a non-GAAP financial measure. We use free cash flow internally as a key indicator of our liquidity and ability to service debt, invest in business combinations, and return money to shareholders and believe this information is useful to investors because it provides an understanding of the cash available to fund these initiatives. For free cash flow purposes, we consider contributions to pension plans to be more comparable to payment of debt, and therefore exclude these contributions from the calculation of free cash flow. | The above table reports free cash flow, which is a non-GAAP financial measure. We use free cash flow internally as a key indicator of our liquidity and ability to service debt, invest in business combinations, and return money to shareholders and believe this information is useful to investors because it provides an understanding of the cash available to fund these initiatives. For free cash flow purposes, we consider contributions to pension plans to be more comparable to payment of debt, and therefore exclude these contributions from the calculation of free cash flow. |

---

------

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **JBT MAREL CORPORATION** | **JBT MAREL CORPORATION** | **JBT MAREL CORPORATION** | **JBT MAREL CORPORATION** | **JBT MAREL CORPORATION** | **JBT MAREL CORPORATION** |
| **NET DEBT CALCULATION** | **NET DEBT CALCULATION** | **NET DEBT CALCULATION** | **NET DEBT CALCULATION** | **NET DEBT CALCULATION** | **NET DEBT CALCULATION** |
| **(Unaudited and in millions)** | **(Unaudited and in millions)** | **(Unaudited and in millions)** | **(Unaudited and in millions)** | **(Unaudited and in millions)** | **(Unaudited and in millions)** |
| | **As of Quarter Ended** | **As of Quarter Ended** | **As of Quarter Ended** | **Change From** | **Change From** |
| | **Q3 2025** | **Q4 2024** | **Q3 2024** | **Prior Year-End** | **Prior Year** |
| Total debt | $1906.7 | $1252.1 | $648.3 | $654.6 | $1258.4 |
| Less: cash and marketable securities | 114.9 | 1228.4 | 534.5 | (1113.5) | (419.6) |
| Net debt | $1791.8 | $23.7 | $113.8 | $1768.1 | $1678.0 |

---

---

| | |
|:---|:---|
| **JBT MAREL CORPORATION** | **JBT MAREL CORPORATION** |
| **BANK TOTAL NET LEVERAGE RATIO CALCULATION** | **BANK TOTAL NET LEVERAGE RATIO CALCULATION** |
| **(Unaudited and in millions)** | **(Unaudited and in millions)** |
| | **Q3 2025** |
| &nbsp;&nbsp;&nbsp;&nbsp;Total debt | $1906.7 |
| &nbsp;&nbsp;&nbsp;&nbsp;Less: cash and marketable securities | 114.9 |
| Net debt | 1791.8 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other items considered debt under the credit agreement | 50.7 |
| Consolidated total indebtedness<sup>(1)</sup> | $1842.5 |
| &nbsp;&nbsp;&nbsp;&nbsp;Trailing twelve months adjusted EBITDA from continuing operations | 531.4 |
| &nbsp;&nbsp;&nbsp;&nbsp;Pro forma EBITDA of recent acquisitions<sup>(2)</sup> | 38.7 |
| &nbsp;&nbsp;&nbsp;Trailing twelve months pro forma adjusted EBITDA | 570.1 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other adjustments net to earnings under the credit agreement | 102.3 |
| Consolidated EBITDA<sup>(1)</sup> | $672.4 |
| Bank total net leverage ratio (Consolidated total indebtedness / Consolidated EBITDA) | 2.7 |
| Total net debt to trailing twelve months pro forma adjusted EBITDA | 3.1 |
| (1) As defined in the credit agreement. | (1) As defined in the credit agreement. |
| (2) Pro forma EBITDA related to the acquisitions in the prior twelve months as defined in the credit agreement. |  |

---

------

---

| | |
|:---|:---|
| **JBT MAREL CORPORATION** | **JBT MAREL CORPORATION** |
| **NON-GAAP FINANCIAL MEASURES** | **NON-GAAP FINANCIAL MEASURES** |
| **RECONCILIATION OF DILUTED EARNINGS PER SHARE FROM CONTINUING OPERATIONS** | **RECONCILIATION OF DILUTED EARNINGS PER SHARE FROM CONTINUING OPERATIONS** |
| **TO ADJUSTED DILUTED EARNINGS PER SHARE GUIDANCE** | **TO ADJUSTED DILUTED EARNINGS PER SHARE GUIDANCE** |
| **(Unaudited and in cents)** | **(Unaudited and in cents)** |
| | **Guidance** |
| | **Full Year 2025** |
| Diluted earnings per share from net income | ($1.05) - ($0.75) |
| &nbsp;&nbsp;&nbsp;&nbsp;Non-GAAP adjustments: |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Restructuring related costs<sup>(1)</sup> | ~ 0.54 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;M&A related costs<sup>(2)</sup> | ~ 2.02 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Acquisition related amortization and depreciation<sup>(3)</sup> | ~ 3.42 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Bridge financing fees and related costs<sup>(4)</sup> | ~ 0.24 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pension plan lump sum payment and termination<sup>(5)</sup> | ~ 2.82 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Loss on investment<sup>(6)</sup> | ~ 0.21 |
| &nbsp;&nbsp;&nbsp;&nbsp;Impact on tax provision from Non-GAAP adjustments<sup>(7)</sup> | ~ (2.10) |
| Adjusted diluted earnings per share from net income | $6.10 - $6.40 |

---

------

---

| | |
|:---|:---|
| **JBT MAREL CORPORATION** | **JBT MAREL CORPORATION** |
| **NON-GAAP FINANCIAL MEASURES** | **NON-GAAP FINANCIAL MEASURES** |
| **RECONCILIATION OF INCOME FROM CONTINUING OPERATIONS TO ADJUSTED EBITDA GUIDANCE** | **RECONCILIATION OF INCOME FROM CONTINUING OPERATIONS TO ADJUSTED EBITDA GUIDANCE** |
| **(Unaudited and in millions)** | **(Unaudited and in millions)** |
| | **Guidance** |
| | **Full Year 2025** |
| (Loss) from continuing operations | ($55.0) - ($39.0) |
| &nbsp;&nbsp;&nbsp;&nbsp;Income tax provision | ($6.0) - ($5.0) |
| &nbsp;&nbsp;&nbsp;&nbsp;Pension expense, other than service cost <sup>(5)</sup> | ~147.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest expense, net | ~105.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other financing income<sup>(8)</sup> | ~ (10.0) |
| &nbsp;&nbsp;&nbsp;&nbsp;Loss on investment<sup>(6)</sup> | ~ 11.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;Restructuring related costs<sup>(1)</sup> | ~ 28.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;M&A related costs<sup>(2)</sup> | ~ 105.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | ~ 265.0 |
| Adjusted EBITDA from continuing operations | $590.0 - $605.0 |
| Revenue | $3760 - $3790 |
| *(Loss) from continuing operations margin* | *(1.5%) - (1.0%)* |
| *Adjusted EBITDA margin* | *15.75% - 16.0%* |
| (1) Restructuring related costs are estimated to be approximately $28 million for the full year 2025. The amount has been divided by our estimate of 52.3 million total shares and dilutive securities to derive earnings per share. | (1) Restructuring related costs are estimated to be approximately $28 million for the full year 2025. The amount has been divided by our estimate of 52.3 million total shares and dilutive securities to derive earnings per share. |
| (2) M&A related costs are estimated to be approximately $105 million for the full year 2025, of which $20 million is related to amortization of inventory step up from business combinations, $27 million is related to integration costs, and $58 million is related to advisory and transaction related costs for both potential and completed M&A transactions and strategy. The amount has been divided by our estimate of 52.3 million total shares and dilutive securities to derive earnings per share. | (2) M&A related costs are estimated to be approximately $105 million for the full year 2025, of which $20 million is related to amortization of inventory step up from business combinations, $27 million is related to integration costs, and $58 million is related to advisory and transaction related costs for both potential and completed M&A transactions and strategy. The amount has been divided by our estimate of 52.3 million total shares and dilutive securities to derive earnings per share. |
| (3) Acquisition related amortization and depreciation is expected to be approximately $180 million for the full year 2025. The amount has been divided by our estimate of 52.3 million total shares and dilutive securities to derive earnings per share. | (3) Acquisition related amortization and depreciation is expected to be approximately $180 million for the full year 2025. The amount has been divided by our estimate of 52.3 million total shares and dilutive securities to derive earnings per share. |
| (4) Bridge financing fees and related costs are estimated to be approximately $12 million for the full year 2025. The amount has been divided by our estimate of 52.3 million total shares and dilutive securities to derive earnings per share. | (4) Bridge financing fees and related costs are estimated to be approximately $12 million for the full year 2025. The amount has been divided by our estimate of 52.3 million total shares and dilutive securities to derive earnings per share. |
| (5) Pension expense, other than service cost for the lump sum payment and termination of the pension plan is estimated to be approximately $147 million for the full year 2025. The amount has been divided by our estimate of 52.3 million total shares and dilutive securities to derive earnings per share. | (5) Pension expense, other than service cost for the lump sum payment and termination of the pension plan is estimated to be approximately $147 million for the full year 2025. The amount has been divided by our estimate of 52.3 million total shares and dilutive securities to derive earnings per share. |
| (6) Loss on investment is estimated to be approximately $11 million for the full year 2025. This is an impairment loss from a joint-venture investment, which occurred in the second quarter. The amount has been divided by our estimate of 52.3 million total shares and dilutive securities to derive earnings per share. | (6) Loss on investment is estimated to be approximately $11 million for the full year 2025. This is an impairment loss from a joint-venture investment, which occurred in the second quarter. The amount has been divided by our estimate of 52.3 million total shares and dilutive securities to derive earnings per share. |
| (7) Impact on tax provision for 2025 tax provision on non-GAAP adjustments was calculated using a tax rate of approximately 23-24% based on a estimate of the tax rate of the country in which the non-GAAP adjustments are originating. | (7) Impact on tax provision for 2025 tax provision on non-GAAP adjustments was calculated using a tax rate of approximately 23-24% based on a estimate of the tax rate of the country in which the non-GAAP adjustments are originating. |
| (8) Other financing income is estimated to be approximately $10 million for the full year 2025. | (8) Other financing income is estimated to be approximately $10 million for the full year 2025. |

---

<br>